HomeHNSA • STO
add
Hansa Biopharma AB
Previous close
kr 30.04
Day range
kr 30.12 - kr 31.94
Year range
kr 19.58 - kr 57.30
Market cap
2.58B SEK
Avg Volume
462.19K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 49.12M | 43.07% |
Operating expense | 186.32M | 3.58% |
Net income | -178.88M | 13.98% |
Net profit margin | -364.16 | 39.87% |
Earnings per share | -1.69 | 48.88% |
EBITDA | -154.83M | 16.48% |
Effective tax rate | -0.47% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 354.42M | -49.73% |
Total assets | 837.27M | -18.66% |
Total liabilities | 1.28B | 2.42% |
Total equity | -441.06M | — |
Shares outstanding | 84.76M | — |
Price to book | -5.78 | — |
Return on assets | -50.39% | — |
Return on capital | -90.44% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -178.88M | 13.98% |
Cash from operations | -111.70M | 40.94% |
Cash from investing | — | — |
Cash from financing | 216.53M | -38.56% |
Net change in cash | 104.22M | -36.27% |
Free cash flow | -83.78M | 37.43% |
About
Founded
2007
Website
Employees
140
